Prostate cancer prevention trials in the USA

Otis Brawley, H. Parnes

Research output: Contribution to journalArticle

Abstract

There is dramatic international variation in prostate cancer mortality rates. The variation suggests that the disease has an environmental cause and encourages the search for a way to prevent it. Androgenic stimulation over a period of time, perhaps due to a high fat diet, has been suggested as a cause of prostate cancer. The corollary to this hypothesis is that lowering androgenic stimulation over time will prevent prostate cancer. 5-Alpha-reductase inhibition through drugs like finasteride have been shown to decrease androgenic stimulation of the prostate. A clinical trial is underway using finasteride to assess this hypothesis. Epidemiological and laboratory studies also suggest that those with high selenium and vitamin E intake have a lower risk of prostate cancer. Recent serendipitous findings of two randomised clinical trials support this. A study to assess these compounds is currently being designed. Other promising but less developed interventions in the chemoprevention of prostate cancer include vitamin D supple-mentation and diet modification.

Original languageEnglish (US)
Pages (from-to)1312-1315
Number of pages4
JournalEuropean Journal of Cancer
Volume36
Issue number10
DOIs
StatePublished - Jan 1 2000
Externally publishedYes

Fingerprint

Prostatic Neoplasms
Finasteride
Cholestenone 5 alpha-Reductase
Diet Therapy
Chemoprevention
High Fat Diet
Selenium
Vitamin E
Vitamin D
Epidemiologic Studies
Prostate
Randomized Controlled Trials
Clinical Trials
Mortality
Pharmaceutical Preparations

Keywords

  • 5-alpha-reductase inhibitor
  • Alpha tocopherol
  • Chemoprevention
  • Clinical trials
  • Prostate
  • Prostate cancer
  • Selenium

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Prostate cancer prevention trials in the USA. / Brawley, Otis; Parnes, H.

In: European Journal of Cancer, Vol. 36, No. 10, 01.01.2000, p. 1312-1315.

Research output: Contribution to journalArticle

Brawley, Otis ; Parnes, H. / Prostate cancer prevention trials in the USA. In: European Journal of Cancer. 2000 ; Vol. 36, No. 10. pp. 1312-1315.
@article{796c9f558f6047199dba0eebe7751390,
title = "Prostate cancer prevention trials in the USA",
abstract = "There is dramatic international variation in prostate cancer mortality rates. The variation suggests that the disease has an environmental cause and encourages the search for a way to prevent it. Androgenic stimulation over a period of time, perhaps due to a high fat diet, has been suggested as a cause of prostate cancer. The corollary to this hypothesis is that lowering androgenic stimulation over time will prevent prostate cancer. 5-Alpha-reductase inhibition through drugs like finasteride have been shown to decrease androgenic stimulation of the prostate. A clinical trial is underway using finasteride to assess this hypothesis. Epidemiological and laboratory studies also suggest that those with high selenium and vitamin E intake have a lower risk of prostate cancer. Recent serendipitous findings of two randomised clinical trials support this. A study to assess these compounds is currently being designed. Other promising but less developed interventions in the chemoprevention of prostate cancer include vitamin D supple-mentation and diet modification.",
keywords = "5-alpha-reductase inhibitor, Alpha tocopherol, Chemoprevention, Clinical trials, Prostate, Prostate cancer, Selenium",
author = "Otis Brawley and H. Parnes",
year = "2000",
month = "1",
day = "1",
doi = "10.1016/S0959-8049(00)00105-2",
language = "English (US)",
volume = "36",
pages = "1312--1315",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Limited",
number = "10",

}

TY - JOUR

T1 - Prostate cancer prevention trials in the USA

AU - Brawley, Otis

AU - Parnes, H.

PY - 2000/1/1

Y1 - 2000/1/1

N2 - There is dramatic international variation in prostate cancer mortality rates. The variation suggests that the disease has an environmental cause and encourages the search for a way to prevent it. Androgenic stimulation over a period of time, perhaps due to a high fat diet, has been suggested as a cause of prostate cancer. The corollary to this hypothesis is that lowering androgenic stimulation over time will prevent prostate cancer. 5-Alpha-reductase inhibition through drugs like finasteride have been shown to decrease androgenic stimulation of the prostate. A clinical trial is underway using finasteride to assess this hypothesis. Epidemiological and laboratory studies also suggest that those with high selenium and vitamin E intake have a lower risk of prostate cancer. Recent serendipitous findings of two randomised clinical trials support this. A study to assess these compounds is currently being designed. Other promising but less developed interventions in the chemoprevention of prostate cancer include vitamin D supple-mentation and diet modification.

AB - There is dramatic international variation in prostate cancer mortality rates. The variation suggests that the disease has an environmental cause and encourages the search for a way to prevent it. Androgenic stimulation over a period of time, perhaps due to a high fat diet, has been suggested as a cause of prostate cancer. The corollary to this hypothesis is that lowering androgenic stimulation over time will prevent prostate cancer. 5-Alpha-reductase inhibition through drugs like finasteride have been shown to decrease androgenic stimulation of the prostate. A clinical trial is underway using finasteride to assess this hypothesis. Epidemiological and laboratory studies also suggest that those with high selenium and vitamin E intake have a lower risk of prostate cancer. Recent serendipitous findings of two randomised clinical trials support this. A study to assess these compounds is currently being designed. Other promising but less developed interventions in the chemoprevention of prostate cancer include vitamin D supple-mentation and diet modification.

KW - 5-alpha-reductase inhibitor

KW - Alpha tocopherol

KW - Chemoprevention

KW - Clinical trials

KW - Prostate

KW - Prostate cancer

KW - Selenium

UR - http://www.scopus.com/inward/record.url?scp=0034199463&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034199463&partnerID=8YFLogxK

U2 - 10.1016/S0959-8049(00)00105-2

DO - 10.1016/S0959-8049(00)00105-2

M3 - Article

C2 - 10882873

AN - SCOPUS:0034199463

VL - 36

SP - 1312

EP - 1315

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 10

ER -